[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 13, Issue 2 (12-2019) ::
Iran J Virol 2019, 13(2): 36-38 Back to browse issues page
Is SARS-CoV-2 a Product of Reverse Genetics Using Vaccinia Virus-Based Recombination?
LARS Hagen *
LARS Hagen
Abstract:   (1358 Views)
This article has no abstract.
Keywords: SARS-CoV-2, COVID-19, vaccinia virus, thymidine kinase
Full-Text [PDF 263 kb]   (1962 Downloads)    
Type of Study: Letter to editor | Subject: General
Received: 2020/04/11 | Accepted: 2019/12/16 | Published: 2019/12/16
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hagen L. Is SARS-CoV-2 a Product of Reverse Genetics Using Vaccinia Virus-Based Recombination?. Iran J Virol 2019; 13 (2) :36-38
URL: http://journal.isv.org.ir/article-1-382-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 2 (12-2019) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4540